Skip to main content

Living with Adult Growth Hormone Deficiency?

Discover a New Path to Wellness Through Clinical Trials

Adult Growth Hormone Deficiency (AGHD) is a rare but serious condition characterized by the inadequate secretion of growth hormone (GH) in adults. This can lead to increased body fat, decreased muscle mass, reduced bone density, and diminished quality of life. Unlike growth hormone deficiency in children, which affects development, AGHD primarily impacts physical function and metabolic health in adults.

Revival Research Institute is conducting Adult Growth Hormone Deficiency clinical trials to explore innovative treatment options. These studies aim to assess the safety and efficacy of investigational therapies that could potentially improve energy levels, cognitive function, body composition, and cardiovascular health in adults living with AGHD.

Are You Eligible to Participate?

To be eligible for our Adult Growth Hormone Deficiency clinical trials, individuals must meet the following criteria:

  • Male or female, age ≥ 18 years
  • Diagnosis of adult growth hormone deficiency (AGHD) as per local practice.

*Additional criteria may apply.

Participation in growth hormone deficiency clinical trials in Texas or other locations provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

Please provide YOUR contact information only.
Adult Growth Hormone Deficiency Clinical Trials

About the Clinical Trials for Adult Growth Hormone Deficiency

Living with Adult Growth Hormone Deficiency (AGHD) can take a real toll on your daily life. It can lead to persistent fatigue, increased body fat, reduced muscle mass, and low energy levels, all of which affect overall well-being.

Revival Research Institute is conducting a long-term, observational clinical study to gather real-world safety data on Sogroya® (somapacitan), a once-weekly growth hormone therapy already prescribed to adults with AGHD. This study focuses on understanding long-term outcomes, especially around potential risks like type 2 diabetes and tumor formation.

Adult Growth Hormone Deficiency Clinical Trials will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with all study procedures. Participants who meet the eligibility criteria after undergoing the screening phase and are chosen to participate will be given the placebo or study treatment.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If you are living with adult growth hormone deficiency, you may qualify for a paid clinical trial focused on potential treatment options for both conditions. After completing the interest from above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation helps advance future treatments for adult growth hormone deficiency.

Age

≥18 Years

Condition

Adult Growth Hormone Deficiency

Location

Texas

Understanding Adult Growth Hormone Deficiency

About Adult Growth Hormone Deficiency

AGHD can be caused by:

  • Pituitary tumors or surgery
  • Traumatic brain injury
  • Radiation therapy
  • Autoimmune inflammation
  • Idiopathic causes (no known cause)

Symptoms of AGHD include:

  • Decreased muscle mass and strength
  • Increased abdominal fat
  • Fatigue and low energy
  • Impaired psychological well-being
  • Elevated cholesterol and cardiovascular risk
  • Poor sleep and cognitive function

Proper treatment for adult growth hormone deficiency includes GH replacement therapy, regular monitoring, and lifestyle changes. Participation in Clinical Trials for adult growth hormone deficiency can provide access to investigational treatments aimed at improving health outcomes.

Frequently Asked Questions (FAQs)

What is adult growth hormone deficiency?

AGHD is a condition in which the pituitary gland fails to produce adequate levels of growth hormone in adulthood. It can develop after childhood or occur due to damage to the hypothalamic-pituitary axis.

What causes AGHD?

Common causes include pituitary tumors, traumatic brain injury, surgery, radiation therapy, and autoimmune conditions. Some cases have no identifiable cause and are considered idiopathic.

How is AGHD diagnosed?

AGHD is diagnosed through hormone stimulation testing, such as the insulin tolerance test (ITT) or glucagon stimulation test. These tests assess the pituitary gland’s ability to secrete growth hormones.

What are the treatment options for AGHD?

The primary treatment for adult growth hormone deficiency is recombinant human growth hormone (rhGH) therapy. It is typically administered as a daily or weekly injection and is monitored for efficacy and side effects.

Why should I participate in a clinical trial?

Participating in Adult Growth Hormone Deficiency clinical trials allows you to access potential new therapies at no cost, receive expert care, and contribute to the development of improved treatments for AGHD and similar endocrine disorders.

Close Menu







    Your information is confidential and used only for study enrollment purposes









      Your information is confidential and used only for study enrollment purposes.